|

AI Driven National Platform for CT cOronary Angiography for clinicaL and industriaL applicatiOns Registry

RECRUITINGSponsored by National Heart Centre Singapore
Actively Recruiting
SponsorNational Heart Centre Singapore
Started2021-10-01
Est. completion2027-12
Eligibility
Age21 Years – 80 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05509010

Summary

The overall aim is to build an AI driven national Platform for CT cOronary angiography for clinicaL and industriaL applicatiOns (APOLLO) for automated anonymization, reporting, Agatston scoring and plaque quantification in CAD. It is a "one-stop" platform spanning diagnosis to clinical management and prognosis, and aid in predicting pharmacotherapy response.

Eligibility

Age: 21 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

1. Age ≥21 years old
2. Signed informed consent
3. Clinically indicated for evaluation by CTCA

Exclusion Criteria:

1. Individuals unable to provide informed consent
2. Known complex congenital heart disease
3. Planned invasive angiography for reasons other than CAD
4. Non-cardiac illness with life expectancy \< 2 years
5. Pregnancy
6. Concomitant participation in another clinical trial in which subject is subject to investigational drug or device
7. Cardiac event and/or coronary revascularization (percutaneous coronary intervention (PCI) and/or coronary artery bypass grafting (CABG) and/or valvular repair/replacement prior to CTCA
8. Glomerular Filtration Rate ≤ 30mL/min
9. Known allergy to iodinated contrast agent
10. Contraindications to beta blockers or nitroglycerin or adenosine

Conditions5

CADCoronary Artery DiseaseCoronary StenosisHeart DiseasePlaques; Epicardial

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.